1832
W. Zeinyeh et al. / Tetrahedron Letters 50 (2009) 1828–1833
Figure 5. Comparative orientation of the benzyl plane in the TS-6a and TS-6b structures.
5. Antonini, I.; Cristalli, G.; Franchetti, P.; Grifantini, M.; Martelli, S.; Petrelli, F. J.
4.3. Alkylating agent effect
Pharm. Sci. 1984, 73, 367–369.
6. (a) Dubey, R. Indian J. Chem., Sect. B 1978, 16, 531; (b) Meravi, M. M.; Montazeri,
N.; Rahmizadeh, M.; Bakavoli, M.; Ghassemzadeh, M. J. Chem. Res. S 2000, 12,
584–585.
7. (a) Itoh, T.; Ono, K.; Sugawara, T.; Mizuno, Y. J. Heterocycl. Chem. 1982, 19, 513–
517; (b) Mizuno, Y.; Ikekawa, N.; Itoh, T.; Saito, K. J. Org. Chem. 1965, 30, 4066–
4071.
8. Ochiai, E. J. Org. Chem. 1953, 18, 534–551.
9. Synthesis of 2-methyl-3H-imidazo[4,5-b]pyridine-4-oxide 4: m-Chloroperbenzoic
acid (90%, 5.690 g, 30 mmol) was added to a suspension of 2-methyl-3H-
Both experimental and computational results have shown that
the nature of benzyl halide slightly influenced N-1/N-3 ratios. In-
deed, calculated relative energetic orders of the TS barriers in sol-
vent were quite similar whatever the alkylating agent was used.
However, optimized TS structures calculated with benzyl iodide
(TS-5b structure) led to a more important steric hindrance between
halide atom and the N-oxide group than with benzyl bromide. Con-
sequently, the energetic gap between TS-5b and TS-5a has ap-
peared slightly larger in the presence of iodide than in the
presence of bromide. This probably explained that more satisfac-
tory N-1/N-3 ratios were obtained with benzyl iodide (Table 2, en-
try 2). However, in the case of N-alkylation of derivative 4, both
steric effects induced either by the presence of a CH3 group on
C-2 position or by the use of a bulky iodide atom have a competi-
tive influence on the structures TS-6a and TS-6b. So, the rationali-
zation of the energetic gap between the latter structures is clearly
more complex than the qualitative understanding previously
given.
imidazo[4,5-b]pyridine
2 (1.587 g, 12 mmol) in chloroform (78 mL). The
mixture was stirred for 4 h at room temperature. Evaporation of the solvent
afforded a yellow powder which was loaded onto silica and was purified by
column chromatography (CH2Cl2/acetone/MeOH = 7:1.5:1.5, Rf = 0.19) to give 4
(1.400 g, 79%) as a pale yellow solid. Mp 266–268 °C. 1H NMR (300 MHz,
DMSO-d6): d = 8.09 (d, 3J(H,H) = 6.4 Hz, 1H, H-5), 7.50 (d, 3J(H,H) = 8.1 Hz, 1H,
H-7), 7.14 (dd, 3J(H,H) = 6.4 and 8.1 Hz, 1H, H-6), 2.53 ppm (s, 3H, CH3). HRMS
(CI): m/z: calcd for C7H8N3O: 150.0666, [M++H]; found: 150.0667.
10. (a) Geen, G. R.; Kincey, P. M.; Spoors, P. G. Tetrahedron Lett. 2001, 42, 1781–
1784; (b) Novak, J.; Linhart, I.; Dvarakova, H.; Kubelka, V. Org. Lett. 2003, 5,
637–639.
11. (a) Wenzel, T.; Seela, F. Helv. Chim. Acta 1996, 79, 169–178; (b) Geen, G. R.;
Grinter, T. J.; Kincey, P. M.; Jarvest, R. L. Tetrahedron 1990, 46, 6903–6914.
12. Typical experimental procedure for N-alkylation of imidazopyridine-4-oxide 3 and
4: K2CO3 (0.442 g, 3.2 mmol) was added under argon to a suspension of the
imidazopyridine-4-oxide (2 mmol) in DMF (5 mL). After stirring at room
temperature for 1 h, benzyl halide (2.4 mmol) was added. After overnight
stirring, water was added and aqueous phase was extracted by AcOEt. The
combined organic extracts were washed with water, dried (Na2SO4) and
evaporated to give a red oil which was purified by column chromatography. In
4.4. Concluding remarks
N-Benzylation of imidazo[4,5-b]pyridine-4-oxide derivatives
substituted or not on C-2 position has been realized to afford, in
each case, a mixture of N-1 and N-3 regioisomers. Both synthetic
and theoretical studies have shown the following. (1) Calculations
have determined that this nucleophilic substitution reaction oc-
curred through a SN2 pathway in solvent phase. (2) Experimental
N-1/N-3 regioselectivities have been confirmed by DFT study. For
each imidazo[4,5-b]pyridine-4-oxide derivatives, electronic factors
(atomic charge and dipolar polarization) allowed concluding that
nucleophilic attack was a slightly more favorable on N-1 site. But
observed N-1/N-3 ratios essentially depended on the relative sta-
bilities of TS involved in the SN2 process in solvent. Our calcula-
tions have confirmed that regioselectivity in N-alkylation of
azaheterocycles has appeared essentially governed by the ‘steric
approach control’. Indeed, the presence of a methyl group on C-2
position has induced additional steric interaction between the ben-
zyl group and the CH3 moiety. Therefore, in the case of 4-oxide 4,
N-3 regioisomer is the major one. Finally, syntheses of 1-substi-
tuted or 3-substituted imidazo[4,5-b]pyridin-7-one derivatives
are in progress in our laboratory.
both cases, this general procedure afforded to
a mixture of N-1/N-3
regioisomers. Regioisomer 5a (CH2Cl2/MeOH = 95:5, Rf = 0.08, white powder,
71%). Mp 174–176 °C. 1H NMR (300 MHz, DMSO-d6, ppm): d = 8.64 (s, 1H, H-2),
8.20 (d, 3J(H,H) = 6.3 Hz, 1H, H-5), 7.60 (d, 3J(H,H) = 8.3 Hz, 1H, H-7), 7.40–7.25
(m, 5H, Harom), 7.21 (dd, 3J(H,H) = 6.3 and 8.3 Hz, 1H, H-6), 5.54 (s, 2H, CH2).
13C NMR (75 MHz, DMSO-d6, ppm): d = 147.5, 146.0, 136.8, 134.1, 131.2, 129.7,
129.2, 128.4, 120.0, 110.7, 49.4. HRMS (CI): m/z: calcd for C13H12N3O:
226.0980, [M++H]; found: 226.0977. Regioisomer 5b: (CH2Cl2/MeOH = 95:5,
Rf = 0.22, yellow powder, 17%). Mp 101–103 °C. 1H NMR (300 MHz, DMSO-d6,
ppm): d = 8.39 (d, 3J(H,H) = 6.8 Hz, 1H, H-5), 8.37 (s, 1H, H-2), 8.32 (d,
3J(H,H) = 7.7 Hz, 1H, H-7), 7.51–7.39 (m, 5H, H-arom), 7.17 (dd, 3J(H,H) = 6.8
and 7.7 Hz, 1H, H-6), 5.72 (s, 2H, CH2). 13C NMR (75 MHz, DMSO-d6, ppm):
d = 160.2, 146.3, 146.1, 133.0, 129.9, 129.5, 129.4, 128.9, 128.6, 112.0, 80.1.
HRMS (EI): m/z: calcd for C13H11N3O: 225.0902, [M+]; found: 225.0903.
Regioisomer 6a: (CH2Cl2/MeOH = 90:10, Rf = 0.25, white powder, 30%). Mp
194–196 °C. 1H NMR (300 MHz, DMSO-d6, ppm): d = 8.12 (d, 3J(H,H) = 6.4 Hz,
1H, H-5), 7.55 (d, 3J(H,H) = 8.3 Hz, 1H, H-7), 7.38–7.27 (m, 3H, H-arom), 7.20–
6.97 (m, 3H, H-6, 2 ꢂ H-arom), 5.53 (s, 2H, CH2), 2.55 (s, 3H, CH3). 13C NMR
(75 MHz, DMSO-d6, ppm): d = 171.5, 149.9, 148.3, 134.0, 130.7, 130.3, 129.5,
127.6, 126.6, 112.2, 80.7, 19.6. HRMS (EI): m/z: calcd for C14H13N3O: 239.1059,
[M+]; found: 239.1058. Regioisomer 6b: (CH2Cl2/MeOH = 90:10, Rf = 0.62,
white powder, 70%). Mp 100–102 °C; 1H NMR (300 MHz, DMSO-d6, ppm):
d = 8.18 (d, 3J(H,H) = 6.8 Hz, 1H, H-5), 8.05 (d, 3J(H,H) = 7.7 Hz, 1H, H-7), 7.50–
7.41 (m, 5H, H-arom), 7.03 (dd, 3J(H,H) = 6.8 and 7.7 Hz, 1H, H-6), 5.67 (s, 2H,
CH2), 2.58 ppm (s, 3H, CH3); 13C NMR (75 MHz, DMSO-d6, ppm): d = 162.9,
154.7, 146.5, 133.7, 132.8, 129.8, 128.7, 127.7, 119.2, 109.7, 47.9, 14.7. HRMS
(EI): m/z: calcd for C14H13N3O: 239.1059, [M+]; found: 239.1055.
13. (a) Chang, L. C. W.; von Frijtag Drabbe Künzel, J. K.; Mulder-Krieger, T.;
Westerhout, J.; Spangenberg, T.; Brussee, J.; IJzerman, A. P. J. Med. Chem. 2007,
50, 828–834; (b) Khanna, I. K.; Weier, R. M.; Lentz, K. T.; Swenton, L.; Lankin, D.
C. J. Org. Chem. 1995, 60, 960–965; (c) Franchetti, P.; Cappellacci, L.; Grifantini,
M.; Messini, L.; Sheikha, G. A.; Loi, A. G.; Tramontano, E.; De Montis, A.; Spiga,
M. G.; La Colla, P. J. Med. Chem. 1994, 37, 3534–3541; (d) Cristalli, G.;
Franchetti, P.; Grifantini, M.; Vittori, S.; Bordoni, T.; Geroni, C. J. Med. Chem.
1987, 30, 1686–1688.
References and notes
1. (a) Chang, G. FEBS Lett. 2003, 555, 102–105; (b) Flügge, U. I.; Van Meer, G. FEBS
Lett. 2006, 580, 997. and further articles of this special issue focused on ABC
transporters.
2. Coombs, G. H. Parasitol. Today 1999, 15, 333–338.
3. Yutilov, Y. M. Heterocycl. Chem. 2005, 89, 159–270. and references therein.
4. Legraverend, M.; Grierson, D. S. Bioorg. Med. Chem. 2006, 14, 3987–4006.
14. Itoh, T.; Sugawara, T.; Mizuno, Y. Nucleosides Nucleotides 1982, 2, 179–190.